Citigroup
IRWD icon

Citigroup’s Ironwood Pharmaceuticals IRWD Stock Holding History

Citigroup’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,800
Closed -$18K – 7606
2020
Q1 		$18K Sell
1,800
-4,800
-73% -$56.4K ﹤0.01% 6756
2019
Q4 		$88K Sell
6,600
-1,800
-21% -$19.8K ﹤0.01% 5873
2019
Q3 		$72K Sell
8,400
-500
-6% -$4.86K ﹤0.01% 5889
2019
Q2 		$97K Sell
8,900
-2,562
-22% -$28.7K ﹤0.01% 5899
2019
Q1 		$130K Sell
11,462
-2,508
-18% -$28K ﹤0.01% 5500
2018
Q4 		$121K Buy
13,970
+13,612
+3,802% +$156K ﹤0.01% 5491
2018
Q3 		$6K Sell
358
-1,672
-82% -$26.4K ﹤0.01% 7462
2018
Q2 		$33K Sell
2,030
-1,791
-47% -$26.5K ﹤0.01% 6603
2018
Q1 		$49K Buy
3,821
+836
+28% +$10.4K ﹤0.01% 6184
2017
Q4 		$37K Sell
2,985
-27,581
-90% -$360K ﹤0.01% 6375
2017
Q3 		$404K Buy
30,566
+30,088
+6,295% +$414K ﹤0.01% 4330
2017
Q2 		$8K Sell
478
-1,432
-75% -$20.8K ﹤0.01% 6598
2017
Q1 		$27K Buy
1,910
+477
+33% +$6.52K ﹤0.01% 6087
2016
Q4 		$18K Buy
1,433
+120
+9% +$1.52K ﹤0.01% 6557
2016
Q3 		$17K Buy
+1,313
New +$15.3K ﹤0.01% 6286
2013
Q4 		– Sell
-28,059
Closed -$278K – 7064
2013
Q3 		$278K Buy
+28,059
New +$275K ﹤0.01% 3892

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citigroup's IRWD Position: Q1 2026 in Review

Citigroup increased its Ironwood Pharmaceuticals (IRWD) stake by 154% in Q1 2026, buying an estimated $98K and bringing the position to 39,405 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #4162.

Citigroup first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.25M in Q1 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Citigroup held 39,405 shares of Ironwood Pharmaceuticals worth $138K as of Q1 2026.
  • Citigroup bought 23,904 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $98K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4162 holding.
  • Citigroup first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Ironwood Pharmaceuticals position peaked at $8.25M in Q1 2024.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.